BELYOND Trademark
Trademark Overview
On Tuesday, November 28, 2023, a trademark application was filed for BELYOND with the United States Patent and Trademark Office. The USPTO has given the BELYOND trademark a serial number of 98288637. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Thursday, November 28, 2024. This trademark is owned by Gilead Sciences Ireland UC. The BELYOND trademark is filed in the Pharmaceutical Products category with the following description:
Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders
General Information
| Serial Number | 98288637 |
| Word Mark | BELYOND |
| Filing Date | Tuesday, November 28, 2023 |
| Status | 680 - APPROVED FOR PUBLICATION |
| Status Date | Thursday, November 28, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 22, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Gilead Sciences Ireland UC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Carrigtohill, Co. Cork
IE |
Trademark Events
| Event Date | Event Description |
| Friday, December 1, 2023 | NEW APPLICATION ENTERED |
| Monday, January 22, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, June 26, 2024 | ASSIGNED TO EXAMINER |
| Thursday, June 27, 2024 | LETTER OF SUSPENSION E-MAILED |
| Thursday, June 27, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Thursday, June 27, 2024 | SUSPENSION LETTER WRITTEN |
| Friday, September 27, 2024 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Friday, November 22, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, November 22, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, November 22, 2024 | ASSIGNED TO LIE |
| Thursday, November 28, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
